Cerevel Therapeutics gains as investors appear more confident on FTC approval for AbbViePost ContentRead MoreABBV, CERECERE – News and Analysis from Seeking Alpha Tags: ARB, MARB, MNA, MRGRRead more articles Previous PostIs Hess (HES) a Solid Growth Stock? 3 Reasons to Think “Yes” Next PostiRobot Is a Falling Knife That’s Too Risky for Most You Might Also Like The Zacks Analyst Blog Highlights Pfizer, Shopify, PG&E, Hess and Datadog 14th August 2024 Kroger set to battle in court with FTC over $25B Albertsons deal on Monday 25th August 2024 Capri ticks higher as investor sees upside even if Tapestry deal dies – report 26th June 2024 Cheniere Partners (CQP) Q2 Earnings Beat, Revenues Fall Y/Y 12th August 2024 Chevron’s Hess Deal Suffers New Blow as Arbitration Drags On 31st July 2024 Why do so many home robots still suck? 1st September 2024